ClinicalTrials.gg
RecruitingNCT07621120Updated Jun 2, 2026

Wearable Accelerometers for Predicting Perioperative Risk in Elderly Patients

An observational study in Post Induction Hypotension, sponsored by Peking Union Medical College Hospital. Recruiting at 1 site in China. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-06-02.

Sponsored by Peking Union Medical College Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 59 studies in Hypotension with a site in China — 26 open to participants now, 29 under way, none of them phase 3. Hypotension · China.

Planned enrollment
16th of 19
100 · median 200
Started
2026
with 10 others
Observational
19 of 59
9 open now
Primary completion
2027-09
later than 24 of 28 live
Registered
51st of 59
by date
Lead sponsor
6 of 59
Peking Union Medical College Hospital

Among the 59 studies in Hypotension with a site in China, this one is the 16th largest by planned enrollment of the 19 observational ones that give a count, is one of 11 that started in 2026, is one of 19 observational ones, reaches primary completion later than 24 of the 28 other live ones, and was the 51st registered.

Hypotension

892 studies on the registry are indexed under Hypotension; 199 are open to participants now.

Browse Hypotension studies →

Open to participants now

26 of the 59 studies in Hypotension with a site in China are open now. Recruiting first, the newest first:

20 more — sign in →

All 26 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 114 Hypotension studies recruiting now, 53 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 59 studies in Hypotension with a site in China, or all of them as a file.
02

Study summary

This single-center prospective cohort study is designed to evaluate whether preoperative physical activity measured by a wearable accelerometer is associated with cardiovascular autonomic function and whether it can help predict post-induction hypotension in elderly patients undergoing elective non-cardiac surgery. Patients aged 65 years or older scheduled for general anesthesia with tracheal intubation will undergo preoperative physical activity monitoring using an ActiGraph wearable accelerometer. Activity-related parameters, including sedentary time, light-, moderate-, and vigorous-intensity activity, daily step count, and sleep duration, will be recorded. Cardiovascular autonomic function will be assessed perioperatively using noninvasive continuous hemodynamic monitoring, with baroreflex sensitivity-related indices derived from continuous blood pressure and beat-to-beat timing data. The primary outcome is post-induction hypotension. Secondary outcomes include early intraoperative hypotension, postoperative complications, and 30-day mortality. This study aims to clarify the relationship between habitual physical activity and autonomic regulation in older surgical patients and to provide evidence supporting future prehabilitation strategies.

Read the detailed description

Older adults undergoing surgery are at increased risk of perioperative hemodynamic instability and postoperative complications. Aging is associated with changes in cardiovascular autonomic regulation, including increased sympathetic activity and reduced parasympathetic tone. Perioperative autonomic dysfunction has been associated with adverse outcomes such as intraoperative hypotension, postoperative pain, postoperative nausea and vomiting, and impaired postoperative recovery. Baroreflex sensitivity is an important quantitative indicator of cardiovascular autonomic function and reflects the heart rate response to changes in blood pressure. Impaired baroreflex function in elderly patients may contribute to a higher risk of post-induction hypotension and other adverse perioperative outcomes.

Physical activity has been shown to be associated with autonomic regulation, and exercise-based interventions may improve baroreflex sensitivity. However, the relationship between preoperative habitual physical activity and baseline autonomic function in elderly surgical patients has not been well defined. Wearable accelerometers provide an objective means of quantifying daily activity and may offer additional value beyond conventional self-reported functional assessments. This study therefore hypothesizes that preoperative physical activity level is associated with baseline cardiovascular autonomic function in elderly patients and that accelerometer-derived activity metrics may be useful in predicting post-induction hypotension and other perioperative outcomes.

This study is a single-center, prospective observational cohort study. Eligible participants will be patients aged 65 years or older, classified as ASA physical status I to III, and scheduled for elective non-cardiac surgery under general anesthesia with tracheal intubation. Major exclusion criteria include severe vascular disease, secondary hypertension, limb tremor disorders such as Parkinson disease, inability to wear a wrist-based accelerometer, inability to measure upper-extremity blood pressure, arrhythmias unsuitable for baroreflex sensitivity measurement, and inability to cooperate with study procedures. Written informed consent will be obtained from all participants or their family members as required.

Before surgery, participants will undergo collection of baseline clinical information, including comorbidities, current medications, and routine preoperative test results. Physical activity and frailty will also be assessed using the short-form International Physical Activity Questionnaire, the FRAIL scale, and the Fried frailty scale. After enrollment, participants will wear an ActiGraph wGT3X-BT accelerometer to continuously record daily physical activity and sleep-related parameters before surgery, including sedentary time, time spent in light-, moderate-, and vigorous-intensity activity, daily step count, and sleep duration.

Perioperative hemodynamic monitoring will include preoperative noninvasive continuous arterial pressure monitoring using the LiDCO rapid V3 system. Under standardized resting conditions, continuous blood pressure and beat-to-beat cardiovascular data will be collected for baroreflex sensitivity analysis. Deep slow breathing testing will also be performed. Preoperative volume-related variables, including time since last fluid intake, intravenous fluid administration, and passive leg raising response assessed by stroke volume change, will be recorded.

During surgery, routine intraoperative monitoring will include pulse oximetry, electrocardiography, and noninvasive blood pressure measurement every 3 minutes. Hemodynamic data at baseline, after induction, and at major intraoperative events will be recorded. Detailed information regarding anesthetic induction and maintenance, including sedative, analgesic, neuromuscular blocking, and vasoactive medications, will also be collected. Postoperative follow-up will be performed on postoperative days 1, 3, and 7 to assess complications according to the Clavien-Dindo classification, postoperative examinations, and quality of recovery using the QoR-15 questionnaire. A 30-day telephone follow-up will be conducted to assess postoperative complications, metabolic equivalent status, and other relevant events.

The primary outcome is post-induction hypotension, defined as systolic blood pressure less than 90 mmHg, mean arterial pressure less than 65 mmHg, or a decrease of more than 30% from baseline within 20 minutes after induction of anesthesia or before surgical incision. Secondary outcomes include the incidence of early intraoperative hypotension, postoperative complications graded by the Clavien-Dindo classification, and all-cause mortality within 30 days after surgery. The planned sample size is 100 patients. Statistical analyses will evaluate associations between preoperative physical activity variables and post-induction hypotension, with adjustment for potential confounding factors such as induction regimen and baseline blood pressure using logistic regression models.

03

Conditions studied

  • Post Induction Hypotension

Browse trials for

Keywords

  • post induction hypotension
  • elderly patient
  • wearable accelerometer
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Elderly patients who will undergo general anesthesia surgery in Peking Union Medical College Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥65 years
  • Scheduled for elective non-cardiac surgery
  • (ASA) physical status I-III
  • Planned to undergo general anesthesia
  • Planned tracheal intubation
  • The patient and family members are able to understand the study protocol, are willing to participate, and provide written

Exclusion criteria

Exclusion Criteria:

  • Severe vascular disease
  • Secondary hypertension
  • Limb tremor disorders, such as Parkinson disease
  • Inability to wear a wrist-based wearable accelerometer for any reason
  • Inability to measure upper-extremity blood pressure
  • Atrial fibrillation or other arrhythmias unsuitable for baroreflex sensitivity measurement
  • Mental or psychiatric conditions resulting in inability to cooperate with study procedures
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Target follow-up
3 Months
Patient registry
Yes

Groups and cohorts

  • observational group

    all of enrolled patients

06

What researchers measure

Primary outcomes

  1. Post induction hypotension

    Systolic blood pressure less than 90 mmHg, mean arterial pressure less than 65 mmHg, or a decrease of more than 30% from baseline.

    Time frame: Within 20 minutes after induction of anesthesia or before surgical incision.

  2. Early intraoperative hypotension

    Systolic blood pressure less than 90 mmHg, mean arterial pressure less than 65 mmHg, or a decrease of more than 30% from baseline.

    Time frame: Within 30 minutes after incision

Secondary outcomes

  1. Postoperative complications

    We use Clavien-Dindo system to grade postoperative complications

    Time frame: Within 30 days after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Finet M, Bellicha A, Sage E, Glorion M, Kennel T, Labro M, Trillat B, Fischler M, Vallee A, Le Guen M, Fessler J. Comprehensive assessment of postoperative mobility during the first days after mini-invasive lung surgery: A prospective observational study. J Clin Anesth. 2023 Jun;86:111048. doi: 10.1016/j.jclinane.2022.111048. Epub 2023 Jan 28. PubMed 36716650 ↗
  • Gardenghi G, Rondon MU, Braga AM, Scanavacca MI, Negrao CE, Sosa E, Hachul DT. The effects of exercise training on arterial baroreflex sensitivity in neurally mediated syncope patients. Eur Heart J. 2007 Nov;28(22):2749-55. doi: 10.1093/eurheartj/ehm208. Epub 2007 Jun 7. PubMed 17561494 ↗

Individual participant data

Plan to share: Undecided — The study team is currently evaluating whether de-identified individual participant data can be shared after study completion and publication, subject to institutional policy, ethics requirements, and data access procedures.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Sep 2027, 14 months later.

Of 149 non-industry observational studies under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 25. This study's planned 14 months is above that.

Counting every sponsor, half of 154 studies reached it within 11 months; a quarter within 5 and three quarters within 25.

How these figures are worked out, and which studies are left out of them.

Registered
May 25, 2026
First posted
Jun 2, 2026
StartEst.
Jun 15, 2026
Primary completionEst.
Sep 1, 2027
CompletionEst.
Dec 31, 2027
Last update
Jun 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07621120
Responsible party
Huang YuGuang (Professor, Peking Union Medical College Hospital) — Principal investigator
First posted
Jun 2, 2026
Start date
Jun 15, 2026 (estimated)
Primary completion
Sep 1, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Jun 2, 2026

Study contacts

Quexuan Cui
Contact
Cuiqx_garfield@126.com
13520921711

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion